Charging for Access Can Allow a Broader Population of Patients to Benefit from Treatment, But Does it Fit the Eexisting Model? A Case Study for an Alternative Approach
Time: 4:30 pm
day: Conference Day One
Details:
Where companies have aspirations for novel ATMPs and rare disease treatments to reach patients wherever they are in the world, charged access can provide a sustainable route. However, increasingly this doesn’t easily fit into the traditional EAP paradigm and sponsors are exploring alternative approaches to operationalising such programs.
